MEN1 and neoplasm: Mice that were Men1+/− in addition to Trp53+/− had tumours in endocrine as well as other sites, implying that increase in total tumour burden, at sites typically associated with either Men1 or Trp53 loss, contributed to the slight decrease in survival in Men1+/−: Trp53+/− animals in comparison with their littermates.